Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
Top Cited Papers
Open Access
- 4 April 2007
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 27 (14) , 3650-3662
- https://doi.org/10.1523/jneurosci.0587-07.2007
Abstract
Neurofibrillary tangles (NFTs) are a pathological hallmark of Alzheimer9s disease and other tauopathies, but recent studies in a conditional mouse model of tauopathy (rTg4510) have suggested that NFT formation can be dissociated from memory loss and neurodegeneration. This suggests that NFTs are not the major neurotoxic tau species, at least during the early stages of pathogenesis. To identify other neurotoxic tau protein species, we performed biochemical analyses on brain tissues from the rTg4510 mouse model and then correlated the levels of these tau proteins with memory loss. We describe the identification and characterization of two forms of tau multimers (140 and 170 kDa), whose molecular weight suggests an oligomeric aggregate, that accumulate early in the pathogenic cascade in this mouse model. Similar tau multimers were detected in a second mouse model of tauopathy (JNPL3) and in tissue from patients with Alzheimer9s disease and FTDP-17 (frontotemporal dementia and parkinsonism linked to chromosome 17). Moreover, levels of the tau multimers correlated consistently with memory loss at various ages in the rTg4510 mouse model. Our findings suggest that accumulation of early-stage aggregated tau species, before the formation of NFT, is associated with the development of functional deficits during the pathogenic progression of tauopathy.Keywords
This publication has 41 references indexed in Scilit:
- An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic miceProceedings of the National Academy of Sciences, 2006
- RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memoryNature, 2006
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoformsJournal of Neurochemistry, 2003
- α-Synuclein, Especially the Parkinson's Disease-associated Mutants, Forms Pore-like Annular and Tubular ProtofibrilsJournal of Molecular Biology, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998
- Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degenerationAnnals of Neurology, 1992
- Spatial localization does not require the presence of local cuesLearning and Motivation, 1981